Browsing by Author Bueno-Topete, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 22  next >
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
AD-MMP8 ADMINISTRATION IN SKELETAL MUSCLE AMELIORATES FIBROSIS IN TAA-INDUCED CIRRHOSISOceguera-Contreras, E; Gordillo-Bastidas, D; Bastidas-Ramirez, BE; Sandoval-Rodriguez, A; Bueno-Topete, M; Armendariz-Borunda, J; Garcia-Banuelos, J--
AD-MMP8 ADMINISTRATION IN SKELETAL MUSCLE AMELIORATES FIBROSIS IN TAA-INDUCED CIRRHOSISOceguera-Contreras, E; Gordillo-Bastidas, D; Bastidas-Ramirez, BE; Sandoval-Rodriguez, A; Bueno-Topete, M; Armendariz-Borunda, J; García-Banuelos, J--
Interferon alpha 2A promotes down-regulation of type III and IV collagens but not TIMP-1 gene expression in experimental fibrosis induced by cholestasis.Bueno-Topete, M; Macias, G; Grijalva, G; Covarrubias, A; Armendariz-Borunda, J--
Interferon alpha 2A promotes down-regulation of type III and IV collagens but not TIMP-1 gene expression in experimental fibrosis induced by cholestasis.Bueno-Topete, M; Macias, G; Grijalva, G; Covarrubias, A; Armendariz-Borunda, J--
KEAP1/NRF2 SIGNALING AND ANTIOXIDANT ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M; Martinez-Rizo, A; Gonzalez-Cuevas, J; Toscano, YS; Sanchez-Orozco, LV; Borunda, JA--
KEAP1/NRF2 SIGNALING AND ANTIOXIDANT ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M; Martinez-Rizo, A; Gonzalez-Cuevas, J; Toscano, YS; Sanchez-Orozco, LV; Borunda, JA--
New Amino Acid Changes in Drug Resistance Sites and HBsAg in Hepatitis B Virus Genotype HFernandez-Galindo, DA; Sanchez-Avila, F; Bobadilla-Morales, L; Gomez-Quiroz, P; Bueno-Topete, M; Armendariz-Borunda, J; Sanchez-Orozco, LV--
New Amino Acid Changes in Drug Resistance Sites and HBsAg in Hepatitis B Virus Genotype HFernandez-Galindo, DA; Sanchez-Avila, F; Bobadilla-Morales, L; Gomez-Quiroz, P; Bueno-Topete, M; Armendariz-Borunda, J; Sanchez-Orozco, LV--
NRF2 EXPRESSION DOES NOT CORRELATE WITH ANTIOXIDANTS ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M; Gonzalez-Cuevas, J; Martinez-Rizo, A; Marquez-Aguirre, AL; Armendariz-Borunda, J--
NRF2 EXPRESSION DOES NOT CORRELATE WITH ANTIOXIDANTS ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M; Gonzalez-Cuevas, J; Martinez-Rizo, A; Marquez-Aguirre, AL; Armendariz-Borunda, J--
PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSISNovarro-Partida, J; Marquez-Aguirre, A; Martinez-Rizo, A; Gonzalez-Cuevas, J; Golvez-Gostelum, FJ; Bueno-Topete, M; Armendariz-Borunda, J--
PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSISNovarro-Partida, J; Marquez-Aguirre, A; Martinez-Rizo, A; Gonzalez-Cuevas, J; Golvez-Gostelum, FJ; Bueno-Topete, M; Armendariz-Borunda, J--
PLASMIN DECREASES TGF beta AND TGF beta-RESPONSIVE GENES ViA SNON AND SMAD7 IN EXPERIMENTAL LIVER FIBROSISMartinez-Rizo, A; Garcia-Benavides, L; Macias-Borragan, J; Gonzalez-Cuevas, J; Troyo-Sanroman, R; Sanchez-Orozco, LV; Armendariz-Borunda, J; Bueno-Topete, M--
PLASMIN DECREASES TGF beta AND TGF beta-RESPONSIVE GENES ViA SNON AND SMAD7 IN EXPERIMENTAL LIVER FIBROSISMartinez-Rizo, A; García-Benavides, L; Macias-Borragan, J; Gonzalez-Cuevas, J; Troyo-Sanroman, R; Sanchez-Orozco, LV; Armendariz-Borunda, J; Bueno-Topete, M--
Plasmin has an important role in SnoN modulation in HSCMartinez-Rizo, A; Bueno-Topete, M; Gonzalez-Cuevas, J; Garcia-Banuelos, J; Delgado-Rizo, V; Troyo-Sanroman, R; Sanchez-Orozco, L; Armendariz-Borunda, J--
Plasmin has an important role in SnoN modulation in HSCMartinez-Rizo, A; Bueno-Topete, M; Gonzalez-Cuevas, J; García-Banuelos, J; Delgado-Rizo, V; Troyo-Sanroman, R; Sanchez-Orozco, L; Armendariz-Borunda, J--
Relationship of fibrogenic polymorphisms (TGF-beta, PAI-1, AT) and pirfenidone treatment in mexican cirrhotic patients with HCVAnnendariz-Borunda, J; Bueno-Topete, M; Rincon, AR; Islas-Carbajal, MC; Munoz-Valle, JE; Oregon-Romero, E; Alvarez-Rodriguez, A; Troyo-Sanroman, R--
Relationship of fibrogenic polymorphisms (TGF-beta, PAI-1, AT) and pirfenidone treatment in mexican cirrhotic patients with HCVAnnendariz-Borunda, J; Bueno-Topete, M; Rincon, AR; Islas-Carbajal, MC; Munoz-Valle, JE; Oregon-Romero, E; Alvarez-Rodriguez, A; Troyo-Sanroman, R--
Relationship of fibrogenic polymorphisms (TGFB, PAI-1, AT) and pirfenidone treatment response in Mexican cirrhotic patients.Armendariz-Borunda, K; Bueno-Topete, M; Munoz-Valle, JF; Oregon-Romero, E; Rincon-Sanchez, AR; Meza, E; Islas-Carvajal, MC; Sandoval, AS--
Relationship of fibrogenic polymorphisms (TGFB, PAI-1, AT) and pirfenidone treatment response in Mexican cirrhotic patients.Armendariz-Borunda, K; Bueno-Topete, M; Munoz-Valle, JF; Oregon-Romero, E; Rincon-Sanchez, AR; Meza, E; Islas-Carvajal, MC; Sandoval, AS--